$HLTH News
Last published 3mo ago
- 3mo agoHLTHTema Launches Healthcare AI ETF (HLTH)Business WireHLTH is the first pure-play ETF focused on AI’s transformation of healthcare. Tema ETFs ("Tema"), a leader in institutional-quality and actively managed exchange-traded funds, today announced the launch of
- 6mo agoHLTHMade Scientific Strengthens Board to Support Scale-Up and Commercial Readiness in Cell Therapy ManufacturingPR NewswireMade Scientific, a U.S.-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the...
- 2y agoHLTHCue Health to Pursue Wind Down of the BusinessBusiness WireCue Health Inc. ("Cue" or the "Company") (NASDAQ:HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of
- 2y agoHLTHCue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)Business WireCue Health Inc. (NASDAQ:HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the
- 2y agoHLTHCue Health to Announce First Quarter Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference
- 2y agoHLTHCue Health Announces Strategic Actions to Position Company for Next StageBusiness WireClint Sever Appointed CEO Board Appoints Two Strategic Advisors Who Bring Significant Industry Expertise Cue Health Inc. ("Cue" or the "Company") (NASDAQ:HLTH), a healthcare technology company, today
- 2y agoHLTHCue Health, Inc. (HLTH) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoHLTHCue Health Reports Fourth Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue" or the "Company") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent Highlights Reported fourth quarter
- 2y agoHLTHCue Health to Announce Fourth Quarter and Full Year 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. In conjunction with the
- 2y agoHLTHCue Health Announces Appointment of Rishi Reddy to Board of DirectorsBusiness WireCue Health (NASDAQ:HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the "Cooperation Agreement") with Tarsadia Investments ("Tarsadia"), and appointed Rishi Reddy to its
- 2y agoHLTHCue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday,
- 3y agoHLTHCue Health Reports Third Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the third quarter 2023. Recent Highlights Reported third quarter total revenue of $17.5 million,
- 3y agoHLTHCue Health to Announce Third Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023. In conjunction with the release, Cue
- 3y agoHLTHConcerned Stockholders of Cue Health Send Letter to BoardBusiness WireCue Health founder and investor, Kelly Day, and certain other stockholders Calls on the Board to reign in undisciplined expansion and cut expenditures Board should include direct stockholder representation to
- 3y agoHLTHPeer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR TestBusiness WireIn largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR Cue Health (NASDAQ:HLTH), a healthcare technology company, announced today the peer-reviewed
- 3y agoHLTHCue Health Adopts Limited-Duration Shareholder Rights PlanBusiness WireBoard of Directors Takes Action to Protect Long-Term Value for All Shareholders Rights Plan Responds to Significant Third-Party Share Accumulation Cue Health (NASDAQ:HLTH), a healthcare technology company, today
- 3y agoHLTHTarsadia Investments Sends Letter to Board of Cue Health, Inc.Business WireCalls on Board to Take Immediate Action to Prevent Further Destruction of Stockholder Value Criticizes Cue's Flawed Capital Allocation and Unsustainable Cost Structure Board Must Undertake Strategic Review and
- 3y agoHLTHCue Health to Present at Upcoming Investor ConferencesBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences: 2023 Wells Fargo Healthcare Conference Presenting via
- 3y agoHLTHCue Health Reports Second Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the second quarter 2023. Recent Highlights Reported second quarter total revenue of $10 million
- 3y agoHLTHCue Health to Announce Second Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its second quarter 2023 financial results on Wednesday, August 9, 2023. In conjunction with the release, Cue
- 3y agoHLTHCue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use TestBusiness WireCue's COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company's innovative test-to-treatment platform Cue Health (NASDAQ:HLTH), a healthcare technology
- 3y agoHLTHCue Health to Present at the Goldman Sachs 44th Annual Global Healthcare ConferenceBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 4:00
- 3y agoHLTHCue Health Reports First Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights Reported first quarter revenue of $24.8
- 3y agoHLTHCue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular TestBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test
- 3y agoHLTHCue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from HomeBusiness WireCue now offers over-the-counter and prescription medications for sexual health, birth control, hair loss, and more Cue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced an expansion of its
- 3y agoHLTHCue Health to Announce First Quarter 2023 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with the release, Cue will
- 3y agoHLTHCue Health Receives FDA Emergency Use Authorization for Molecular Mpox TestBusiness WireAuthorized to be used in professional point-of-care settings, the nucleic acid amplification test can detect mpox virus and deliver results in 25 minutes Cue Health ("Cue") (NASDAQ:HLTH), a healthcare technology
- 3y agoHLTHCue Health Reports Fourth Quarter and Full-Year 2022 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022. Recent and Full-Year 2022 Highlights Reported fourth quarter
- 3y agoHLTHCue Health's New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your HealthBusiness WireGet actionable health information and convenient access to treatment for a wide range of general health & wellness conditions, including sexual, heart, and metabolic health Cue Health ("Cue") (NASDAQ:HLTH), a
- 3y agoHLTHCue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment JourneyBusiness WireNew educational resources will make it easier for people at high risk of progression to severe COVID-19 to protect their health through accessible and timely health information Cue Health ("Cue") (NASDAQ:HLTH), the
- 3y agoHLTHCue Health to Announce Fourth Quarter and Full-Year 2022 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wednesday, March 15, 2023. In conjunction with the
- 3y agoHLTHCue Health to Participate at Upcoming Investor ConferencesBusiness WireCue Health ("Cue") (NASDAQ:HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the following investor conferences: BTIG MedTech,
- 3y agoHLTHCue Health Selected by Minnesota Department of Health to Provide Statewide Telehealth to Treatment Services to all Minnesota Residents at No CostBusiness WireIn partnership with Minnesota Department of Health, Cue's digital service offers an integrated solution to provide COVID-19 treatment options access across all populations Cue Health ("Cue") (NASDAQ:HLTH), the
- 3y agoHLTHCue Health Announces Appointment of Josh Ghaim, Ph.D. and Sachin Jain, M.D. to its Board of DirectorsBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that Josh Ghaim, Ph.D. and Sachin Jain, M.D. have joined its Board of Directors.
- 4y agoHLTHCue Health Reports Third Quarter 2022 ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the third quarter of 2022. Recent Highlights Revenue of $69.6 million in the third quarter of 2022,
- 4y agoHLTHCue Health to Announce Third Quarter 2022 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022. In conjunction with the release, Cue
- 4y agoHLTHCue Health Applies with FDA for Emergency Use Authorization of its Cue Flu + COVID-19 Molecular TestPR NewswireAt-home or point-of-care test can simultaneously detect and differentiate between flu and COVID-19, delivering diagnostic results to mobile devices in 25 minutes SAN DIEGO, Oct. 4, 2022 /PRNewswire/ -- Cue Health ("Cue") (NASDAQ:HLTH), a healthcare tec
- 4y agoHLTHCue Health Appoints Suzanne Stone as New Chief Commercial OfficerPR NewswireSAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced that it has appointed Suzanne Stone as its new Chief Commercial Officer. Stone brings over 25 years of experience building h
- 4y agoHLTHCue Health Appoints David Tsay, MD, PhD, as Chief Medical OfficerPR NewswireDr. Tsay Brings Two Decades of Expertise in Clinical Medicine, Research, and Health Technology to Cue SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced that it has appointed
- 4y agoHLTHCue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® Flu Molecular TestPR NewswireSAN DIEGO, Sept. 1, 2022 /PRNewswire/ -- Cue Health ("Cue") (NASDAQ:HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue® Flu Molecular Test for at-home and point-of-car
- 4y agoHLTHCue Health to Present at the Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022 at 4:40 p.m. Eastern Time in New York,
- 4y agoHLTHCue Health Launches Cue Care™ Nationwide to Provide Same-Day, At-Home, Test-to-Treatment Service for COVID-19PR NewswireSAN DIEGO, Aug. 29, 2022 /PRNewswire/ -- Cue Health Inc. (NASDAQ:HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced the nationwide launch of Cue Care™, its same-day, at-home, test-to-treatment
- 4y agoHLTHCue Health Provides Enhanced Care & Protection for Immunocompromised Populations & Clinical Care Teams at Fresenius Kidney CarePR NewswireSAN DIEGO, Aug. 24, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today announced a new collaboration with Fresenius Kidney Care to provide the most accurate* COVID-19 self-test to certain patients and clini
- 4y agoHLTHIndependent Study Shows Cue Health's Molecular COVID-19 Test is as Accurate as a Lab-Based PCR TestPR NewswireIn largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR SAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ:HLTH) announced today the preprint publication of
- 4y agoHLTHCue Health Reports Second Quarter 2022 ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, today reported financial results for the second quarter of 2022. Recent Highlights Revenue of $87.7 million in the second quarter of 2022 exceeds guidance with stronger than
- 4y agoHLTHCue Health to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 ConferenceBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on Tuesday, August 16, 2022. About Cue HealthCue is a
- 4y agoHLTHCue Health to Announce Second Quarter 2022 Financial ResultsBusiness WireCue Health Inc. ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and we
- 4y agoHLTHCue Health Appoints Allison Blackwell Chief Human Resources OfficerPR NewswireSeasoned Leader Brings Extensive Experience in Building Diverse, Inclusive Healthcare Organizations SAN DIEGO, July 13, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ:HLTH), a health technology company, today announced that it has appointed Allis
- 4y agoCALBGOOGLHLTHUSERHow Women Lead Appoints Sue Harnett, Shannon Nash, Vanessa Small & Millicent Tracey to Executive BoardBusiness WireShreya Jain and Christy Swindling Kennedy Join Organization's Silicon Valley Board How Women Lead, a national organization of top executive women focused on activating their individual and collective power to influence the change they want to see in
- 4y agoHLTHCue Health to Present at Upcoming Investor ConferencesBusiness WireCue Health ("Cue") (NASDAQ:HLTH), a healthcare technology company, announced today that its management team will present at the following conferences: 43rd Annual Goldman Sachs Global Healthcare ConferencePresenting on Wednesday, June 15, 2022 at 6